Ontology highlight
ABSTRACT: Background
Effective gastric carcinoma (GC) chemotherapy is subject to many in vitro and in vivo barriers, such as tumor microenvironment and multidrug resistance.Materials and methods
Herein, we developed a hyaluronic acid (HA)-modified silica nanoparticle (HA-SiLN/QD) co-delivering quercetin and doxorubicin (DOX) to enhance the efficacy of GC therapy (HA-SiLN/QD). The HA modification was done to recognize overexpressed CD44 receptors on GC cells and mediate selective tumor targeting. In parallel, quercetin delivery decreased the expression of Wnt16 and P-glycoprotein, thus remodeling the tumor microenvironment and reversed multidrug resistance to facilitate DOX activity.Results
Experimental results demonstrated that HA-SiLN/QD was nanoscaled particles with prefera
SUBMITTER: Fang J
PROVIDER: S-EPMC6135215 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature